Literature DB >> 15093193

A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors.

Kenneth N Barton1, Xueqing Xia, Hui Yan, Hans Stricker, Gregory Heisey, Fang-Fang Yin, Tavarekere N Nagaraja, Guopei Zhu, Andrew Kolozsvary, Joseph D Fenstermacher, Mei Lu, Jae Ho Kim, Svend O Freytag, Stephen L Brown.   

Abstract

This study describes a quantitative method to measure the magnitude and distribution of gene expression following local delivery of an adenoviral vector containing the human sodium iodide symporter (hNIS) reporter gene into the canine prostate. Following systemic administration of Na(99m)TcO(4), autoradiographs of prostate sections depicting hNIS-dependent (99m)TcO(4)(-) uptake were digitized and stacked to produce a three-dimensional reconstruction of gene expression. Frequency histograms reflecting hNIS gene expression magnitude and volume were used to quantify hNIS function. The method demonstrated submillimeter resolution allowing for precise measurements of gene expression magnitude and volume in vivo. The method developed here could be applied to other reporter gene systems in which the readout can be digitized from thin tissue sections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093193     DOI: 10.1016/j.ymthe.2004.01.011

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  10 in total

1.  Monitoring adenoviral based gene delivery in rat glioma by molecular imaging.

Authors:  Nadimpalli Ravi S Varma; Kenneth N Barton; Branislava Janic; Adarsh Shankar; Asm Iskander; Meser M Ali; Ali S Arbab
Journal:  World J Clin Oncol       Date:  2013-11-10

2.  Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.

Authors:  Kenneth N Barton; Hans Stricker; Mohamed A Elshaikh; Jan Pegg; Jingfang Cheng; Yingshu Zhang; Kastytis C Karvelis; Mei Lu; Benjamin Movsas; Svend O Freytag
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

3.  Cord blood endothelial progenitor cells as therapeutic and imaging probes.

Authors:  Branislava Janic; Ali S Arbab
Journal:  Imaging Med       Date:  2012-08-01

4.  Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate.

Authors:  Kenneth N Barton; Hans Stricker; Stephen L Brown; Mohamed Elshaikh; Ibrahim Aref; Mei Lu; Jan Pegg; Yingshu Zhang; Kastytis C Karvelis; Farzan Siddiqui; Jae Ho Kim; Svend O Freytag; Benjamin Movsas
Journal:  Mol Ther       Date:  2008-08-19       Impact factor: 11.454

Review 5.  Armed replicating adenoviruses for cancer virotherapy.

Authors:  J J Cody; J T Douglas
Journal:  Cancer Gene Ther       Date:  2009-02-06       Impact factor: 5.987

6.  Increasing the efficacy of oncolytic adenovirus vectors.

Authors:  Karoly Toth; William S M Wold
Journal:  Viruses       Date:  2010-08-27       Impact factor: 5.818

7.  Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma.

Authors:  Nadimpalli Ravi S Varma; Branislava Janic; A S M Iskander; Adarsh Shankar; Mohammed P I Bhuiyan; Hamid Soltanian-Zadeh; Quan Jiang; Kenneth Barton; Meser M Ali; Ali S Arbab
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

Review 8.  The quest for a better insight into physiology of fluids and barriers of the brain: the exemplary career of Joseph D. Fenstermacher.

Authors:  Adam Chodobski; Jean-François Ghersi-Egea; Charles Nicholson; Tavarekere N Nagaraja; Joanna Szmydynger-Chodobska
Journal:  Fluids Barriers CNS       Date:  2015-01-12

9.  Improved Noninvasive In Vivo Tracking of AAV-9 Gene Therapy Using the Perchlorate-Resistant Sodium Iodide Symporter from Minke Whale.

Authors:  Susanna C Concilio; Lukkana Suksanpaisan; Linh Pham; Kah-Whye Peng; Stephen J Russell
Journal:  Mol Ther       Date:  2020-09-30       Impact factor: 11.454

Review 10.  A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.

Authors:  Susanna C Concilio; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther Oncolytics       Date:  2021-03-10       Impact factor: 7.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.